-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million.
  • GlucoTrack (NASDAQ:GCTK) shares moved upwards by 35.62% to $0.5. The company's market cap stands at $2.8 million.
  • OmniAb (NASDAQ:OABI) shares moved upwards by 22.49% to $4.14. The company's market cap stands at $490.0 million.
  • Anbio Biotechnology (NASDAQ:NNNN) shares increased by 20.13% to $10.5. The market value of their outstanding shares is at $383.6 million.
  • Quantum BioPharma (NASDAQ:QNTM) shares increased by 18.42% to $4.5. The market value of their outstanding shares is at $24.3 million.
  • Ocular Therapeutix (NASDAQ:OCUL) shares rose 11.35% to $11.18. The market value of their outstanding shares is at $2.2 billion.

Losers

  • EyePoint (NASDAQ:EYPT) stock declined by 61.7% to $5.64 during Monday's pre-market session. The market value of their outstanding shares is at $1.2 billion.
  • Apimeds Pharmaceuticals (AMEX:APUS) shares declined by 30.11% to $3.18. The company's market cap stands at $6.8 million. As per the press release, Q2 earnings came out yesterday.
  • IM Cannabis (NASDAQ:IMCC) shares declined by 27.61% to $0.09. The market value of their outstanding shares is at $1.1 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock declined by 22.62% to $3.08. The company's market cap stands at $8.7 million. The company's, Q2 earnings came out yesterday.
  • Citius Oncology (NASDAQ:CTOR) shares declined by 18.67% to $0.74. The company's market cap stands at $84.5 million. The company's, Q3 earnings came out yesterday.
  • iTonic Holdings (NASDAQ:ITOC) shares decreased by 17.5% to $0.26. The market value of their outstanding shares is at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending